Dialectic Capital Management’s Puma Biotechnology PBYI Stock Holding History

Dialectic Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,000	Closed	-$1.17M	–	186
2015 Q2	$1.17M	Buy	10,000 +2,500	+33%	+$453K	0.35%	99
2015 Q1	$1.77M	Sell	7,500 -2,500	-25%	-$534K	0.31%	105
2014 Q4	$1.89M	Hold	10,000	–	–	0.36%	107
2014 Q3	$2.38M	Buy	+10,000	New	+$2.05M	0.56%	61

Other funds holding PBYI

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return